GSK-204856

Study Sponsor: GSK

Study Title

A Phase I, Randomized, Placebo-Controlled, Double-Blind (sponsor unblind), Three Part Study to Evaluate the Safety, Tolerability, Preliminary PK and PD of Single and Repeat Oral Doses of GSK3008356 in Healthy Subjects and Obese Subjects

Medicine or Vaccine (generic name)

GSK3008356

Sponsor Identification Number

204856

Trial Registry Identification Number(#'s)

NCT02742766

Medical Condition

Healthy Volunteers

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204856

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02742766

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. The data for this study is available in CDISC format.

Date Added to this Site

May 2019